Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 1/20 | 0.50 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20205672 | 1.00 | GLO1 (0.50) | GLO1ZDHHC7FAAHNPSR1ABCB1 | |
| SCHEMBL3915569 | 1.00 | GLO1 (0.50) | GLO1ZDHHC7FAAHNPSR1ABCB1 | |
| SCHEMBL12693570 | 0.92 | ZDHHC7 (0.45) | GLO1ZDHHC7FAAHNPSR1ABCB1 | |
| SCHEMBL10741995 | 0.87 | GLO1 (0.56) | GLO1NPSR1ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL20205684 | 0.87 | FAAH (0.43) | GLO1ZDHHC7FAAHNPSR1ABCB1 | |
| SCHEMBL20205354 | 0.85 | LMNA (0.44) | ZDHHC7FAAHABCB1ACE2LMNA | |
| SCHEMBL20187390 | 0.81 | EP300 (0.46) | ZDHHC7ACE2LMNAMAPTGPR84 | |
| SCHEMBL20189229 | 0.81 | EP300 (0.46) | ZDHHC7ACE2LMNAMAPTGPR84 | |
| SCHEMBL20187391 | 0.81 | EP300 (0.46) | ZDHHC7ACE2LMNAMAPTGPR84 | |
| SCHEMBL20205355 | 0.78 | ZDHHC7 (0.50) | ZDHHC7FAAHABCB1ACE2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263631-A1 | PRO-PERFUME COMPOSITIONS | FIRMENICH SA (CH) | 2025-08-21 | — | — | US | claimed |
| US-20230024269-A1 | Pro-Perfume Compositions | FIRMENICH SA (CH) | 2023-01-26 | — | — | US | claimed |
| EP-4034073-A1 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2022-08-03 | — | — | EP | claimed |
| CN-114727924-A | Pro-fragrance compositions | 弗门尼舍有限公司 | 2022-07-08 | — | — | CN | claimed |
| WO-2021123144-A1 | PRO-PERFUME COMPOSITIONS | FIRMENICH SA (CH) | 2021-06-24 | — | — | WO | claimed |
| US-20190276387-A1 | PRECURSOR COMPOUNDS FOR FRAGRANT ALDEHYDES | GIVAUDAN SA (CH) | 2019-09-12 | — | — | US | claimed |
| US-9585362-B2 | Fragrance compounds | GIVAUDAN S.A. (CH) | 2017-03-07 | — | — | US | claimed |
| US-20160286753-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2016-10-06 | — | — | US | claimed |
| US-9447364-B2 | Fragrance compounds | GIVAUDAN S.A. (CH) | 2016-09-20 | — | — | US | claimed |
| US-20150247109-A1 | FRAGRANCE COMPOUNDS | Givaudan, S.A. (CH) | 2015-09-03 | — | — | US | claimed |
| US-9057041-B2 | Fragrance compounds | Givaudan, S.A. (CH) | 2015-06-16 | — | — | US | claimed |
| US-20140031270-A1 | Fragrance Compounds | GIVAUDAN S.A. (CH) | 2014-01-30 | — | — | US | claimed |
| US-8575386-B2 | Fragrance compounds | GIVAUDAN S.A. (CH) | 2013-11-05 | — | — | US | claimed |
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | disclosed |
| EP-3966197-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2026-01-28 | — | — | EP | disclosed |
| EP-4676920-A1 | PHOTOLABILE CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED DELIVERY OF ACTIVE ALDEHYDES AND KETONES | Firmenich SA (CH) | 2026-01-14 | — | — | EP | disclosed |
| EP-2032516-B1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2012-09-26 | — | — | EP | disclosed |
| US-20090202464-A1 | Fragrance Compounds | GIVAUDAN S.A. (CH) | 2009-08-13 | — | — | US | disclosed |
| EP-2032516-A1 | FRAGRANCE COMPOUNDS | Givaudan SA (CH) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007143873-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202464-A1 | Fragrance Compounds | OR10J3, OR51E2, TAS2R5 | GLO1 1606/4885ZDHHC7 2746/4885FAAH 1234/4885 |
| US-20190276387-A1 | PRECURSOR COMPOUNDS FOR FRAGRANT ALDEHYDES | HAAO, B3GNT2, NAA40 | GLO1 1900/4885ZDHHC7 251/4885FAAH 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.